Gasparri A, Pocaterra A, Colombo B, Taie G, Gnasso C, Gori A
J Exp Clin Cancer Res. 2025; 44(1):88.
PMID: 40055773
PMC: 11889887.
DOI: 10.1186/s13046-025-03352-4.
Geyer M, Geyer F, Reuning U, Klapproth S, Wolff K, Nieberler M
Head Face Med. 2024; 20(1):37.
PMID: 38890650
PMC: 11184753.
DOI: 10.1186/s13005-024-00437-x.
Monieri M, Rainone P, Sacchi A, Gori A, Gasparri A, Coliva A
Int J Biol Sci. 2023; 19(1):156-166.
PMID: 36594095
PMC: 9760430.
DOI: 10.7150/ijbs.76148.
Corti A, Anderluzzi G, Curnis F
Pharmaceutics. 2022; 14(12).
PMID: 36559048
PMC: 9785887.
DOI: 10.3390/pharmaceutics14122555.
Brzozowska E, Deshmukh S
Int J Mol Sci. 2022; 23(20).
PMID: 36293202
PMC: 9603893.
DOI: 10.3390/ijms232012346.
A comparison of Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin αβ.
Huynh T, Sreekumar S, Mpoy C, Rogers B
Oncotarget. 2022; 13:360-372.
PMID: 35186193
PMC: 8849274.
DOI: 10.18632/oncotarget.28197.
Optimized serum stability and specificity of an αvβ6 integrin-binding peptide for tumor targeting.
Cardle I, Jensen M, Pun S, Sellers D
J Biol Chem. 2021; 296:100657.
PMID: 33857478
PMC: 8138772.
DOI: 10.1016/j.jbc.2021.100657.
Cooperative signaling between integrins and growth factor receptors in fibrosis.
Maldonado H, Hagood J
J Mol Med (Berl). 2021; 99(2):213-224.
PMID: 33392631
DOI: 10.1007/s00109-020-02026-2.
NIR Imaging of the Integrin-Rich Head and Neck Squamous Cell Carcinoma Using Ternary Copper Indium Selenide/Zinc Sulfide-Based Quantum Dots.
Yakavets I, Francois A, Guiot M, Lequeux N, Fragola A, Pons T
Cancers (Basel). 2020; 12(12).
PMID: 33322532
PMC: 7764319.
DOI: 10.3390/cancers12123727.
Clinical Translation of a Ga-Labeled Integrin αβ-Targeting Cyclic Radiotracer for PET Imaging of Pancreatic Cancer.
Feng X, Wang Y, Lu D, Xu X, Zhou X, Zhang H
J Nucl Med. 2020; 61(10):1461-1467.
PMID: 32086242
PMC: 7539652.
DOI: 10.2967/jnumed.119.237347.
Preclinical evaluation of [F]FB-A20FMDV2 as a selective marker for measuring αβ integrin occupancy using positron emission tomography in rodent lung.
Onega M, Parker C, Coello C, Rizzo G, Keat N, Ramada-Magalhaes J
Eur J Nucl Med Mol Imaging. 2020; 47(4):958-966.
PMID: 31897589
PMC: 7075836.
DOI: 10.1007/s00259-019-04653-5.
Recent advances in graphene-based nanomaterials: properties, toxicity and applications in chemistry, biology and medicine.
Yao J, Wang H, Chen M, Yang M
Mikrochim Acta. 2019; 186(6):395.
PMID: 31154528
DOI: 10.1007/s00604-019-3458-x.
Small-animal SPECT/CT imaging of cancer xenografts and pulmonary fibrosis using a Tc-labeled integrin αvβ6-targeting cyclic peptide with improved stability.
Liu H, Gao L, Yu X, Zhong L, Shi J, Jia B
Biophys Rep. 2018; 4(5):254-264.
PMID: 30533490
PMC: 6245143.
DOI: 10.1007/s41048-018-0071-1.
Assessment of Right Ventricular Function in the Research Setting: Knowledge Gaps and Pathways Forward. An Official American Thoracic Society Research Statement.
Lahm T, Douglas I, Archer S, Bogaard H, Chesler N, Haddad F
Am J Respir Crit Care Med. 2018; 198(4):e15-e43.
PMID: 30109950
PMC: 6835085.
DOI: 10.1164/rccm.201806-1160ST.
Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6.
Farber S, Wurzer A, Reichart F, Beck R, Kessler H, Wester H
ACS Omega. 2018; 3(2):2428-2436.
PMID: 30023833
PMC: 6045477.
DOI: 10.1021/acsomega.8b00035.
Exploring the Role of RGD-Recognizing Integrins in Cancer.
Nieberler M, Reuning U, Reichart F, Notni J, Wester H, Schwaiger M
Cancers (Basel). 2017; 9(9).
PMID: 28869579
PMC: 5615331.
DOI: 10.3390/cancers9090116.
RGD-Binding Integrins in Head and Neck Cancers.
Ahmedah H, Patterson L, Shnyder S, Sheldrake H
Cancers (Basel). 2017; 9(6).
PMID: 28587135
PMC: 5483875.
DOI: 10.3390/cancers9060056.
Tumor-targeting peptides from combinatorial libraries.
Liu R, Li X, Xiao W, Lam K
Adv Drug Deliv Rev. 2016; 110-111:13-37.
PMID: 27210583
PMC: 5856482.
DOI: 10.1016/j.addr.2016.05.009.
The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.
Hausner S, Bauer N, Hu L, Knight L, Sutcliffe J
J Nucl Med. 2015; 56(5):784-90.
PMID: 25814519
PMC: 4559355.
DOI: 10.2967/jnumed.114.150680.
Surface engineering of graphene-based nanomaterials for biomedical applications.
Shi S, Chen F, Ehlerding E, Cai W
Bioconjug Chem. 2014; 25(9):1609-19.
PMID: 25117569
PMC: 4166029.
DOI: 10.1021/bc500332c.